1. Home
  2. PLX vs GTI Comparison

PLX vs GTI Comparison

Compare PLX & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLX
  • GTI
  • Stock Information
  • Founded
  • PLX 1993
  • GTI 2019
  • Country
  • PLX Israel
  • GTI Malaysia
  • Employees
  • PLX N/A
  • GTI N/A
  • Industry
  • PLX Biotechnology: Biological Products (No Diagnostic Substances)
  • GTI
  • Sector
  • PLX Health Care
  • GTI
  • Exchange
  • PLX Nasdaq
  • GTI NYSE
  • Market Cap
  • PLX 132.5M
  • GTI 138.7M
  • IPO Year
  • PLX 1998
  • GTI N/A
  • Fundamental
  • Price
  • PLX $1.76
  • GTI $0.23
  • Analyst Decision
  • PLX
  • GTI
  • Analyst Count
  • PLX 0
  • GTI 0
  • Target Price
  • PLX N/A
  • GTI N/A
  • AVG Volume (30 Days)
  • PLX 382.4K
  • GTI 2.0M
  • Earning Date
  • PLX 11-14-2024
  • GTI 12-31-2024
  • Dividend Yield
  • PLX N/A
  • GTI N/A
  • EPS Growth
  • PLX N/A
  • GTI N/A
  • EPS
  • PLX N/A
  • GTI N/A
  • Revenue
  • PLX $45,667,000.00
  • GTI N/A
  • Revenue This Year
  • PLX N/A
  • GTI N/A
  • Revenue Next Year
  • PLX $88.94
  • GTI N/A
  • P/E Ratio
  • PLX N/A
  • GTI N/A
  • Revenue Growth
  • PLX N/A
  • GTI N/A
  • 52 Week Low
  • PLX $0.82
  • GTI $0.19
  • 52 Week High
  • PLX $1.90
  • GTI $14.00
  • Technical
  • Relative Strength Index (RSI)
  • PLX 62.98
  • GTI 22.54
  • Support Level
  • PLX $1.60
  • GTI $0.82
  • Resistance Level
  • PLX $1.83
  • GTI $1.50
  • Average True Range (ATR)
  • PLX 0.08
  • GTI 0.52
  • MACD
  • PLX -0.02
  • GTI -0.22
  • Stochastic Oscillator
  • PLX 71.15
  • GTI 1.34

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: